4//SEC Filing
Cavanagh Shawn 4
Accession 0001209191-18-045745
CIK 0000820081other
Filed
Aug 6, 8:00 PM ET
Accepted
Aug 7, 5:53 PM ET
Size
28.1 KB
Accession
0001209191-18-045745
Insider Transaction Report
Form 4
CAMBREX CORPCBM
Cavanagh Shawn
Executive Vice President & COO
Transactions
- Exercise/Conversion
Common Stock
2018-08-06$16.91/sh+10,000$169,050→ 27,658 total - Exercise/Conversion
Common Stock
2018-08-06$17.81/sh+10,000$178,100→ 37,658 total - Exercise/Conversion
Common Stock
2018-08-06$40.65/sh+399$16,219→ 55,557 total - Sale
Common Stock
2018-08-06$63.16/sh−8,744$552,271→ 17,658 total - Exercise/Conversion
Common Stock
2018-08-06$41.35/sh+17,500$723,713→ 55,158 total - Sale
Common Stock
2018-08-06$62.11/sh−29,155$1,810,817→ 26,402 total - Exercise/Conversion
Common Stock
2018-08-07$40.65/sh+8,351$339,468→ 26,009 total - Sale
Common Stock
2018-08-07$62.89/sh−8,351$525,194→ 17,658 total - Exercise/Conversion
Stock Option (right to buy)
2018-08-06+10,000→ 0 totalExercise: $16.91Exp: 2020-10-28→ Common Stock (10,000 underlying) - Exercise/Conversion
Stock Option (right to buy)
2018-08-06+10,000→ 10,000 totalExercise: $17.81Exp: 2021-10-22→ Common Stock (10,000 underlying) - Exercise/Conversion
Stock Option (right to buy)
2018-08-06+17,500→ 17,500 totalExercise: $41.35Exp: 2022-10-21→ Common Stock (17,500 underlying) - Exercise/Conversion
Stock Option (right to buy)
2018-08-06+399→ 34,601 totalExercise: $40.65Exp: 2023-10-26→ Common Stock (399 underlying) - Exercise/Conversion
Stock Option (right to buy)
2018-08-07+8,351→ 26,250 totalExercise: $40.65Exp: 2023-10-26→ Common Stock (8,351 underlying)
Footnotes (6)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.65 to $62.65 inclusive. The reporting person undertakes to provide to Cambrex Corporation, any security holder of Cambrex Corporation, or staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Footnote 1 to this Form 4.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.70 to $63.50 inclusive. The reporting person undertakes to provide to Cambrex Corporation, any security holder of Cambrex Corporation, or staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Footnote 2 to this Form 4.
- [F3]The option representing a right to purchase 40,000 shares became exercisable in four equal installments beginning October 28, 2014, which was the first anniversary of the date on which the option was granted
- [F4]The option representing a right to purchase 40,000 shares became exercisable in four equal installments beginning October 22, 2015, which was the first anniversary of the date on which the option was granted.
- [F5]The option representing a right to purchase 35,000 shares became exercisable in four equal installments beginning October 21, 2016, which was the first anniversary of the date on which the option was granted.
- [F6]The option representing a right to purchase 35,000 shares became exercisable in four equal installments beginning October 26, 2017, which was the first anniversary of the date on which the option was granted.
Documents
Issuer
CAMBREX CORP
CIK 0000820081
Entity typeother
Related Parties
1- filerCIK 0001353221
Filing Metadata
- Form type
- 4
- Filed
- Aug 6, 8:00 PM ET
- Accepted
- Aug 7, 5:53 PM ET
- Size
- 28.1 KB